| Date | Time | Source | Headline | Symbol | Company |
| 11/22/2023 | 4:15PM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/21/2023 | 1:21PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/17/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 5:02PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 5:00PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:58PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:56PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:54PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:52PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:50PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:48PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:46PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:44PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:42PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:39PM | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:35PM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:31PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:11PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:11PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:10PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:10PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:06PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/11/2023 | 4:04PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/07/2023 | 4:05PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/03/2023 | 4:06PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/01/2023 | 7:27PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 08/01/2023 | 7:05AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:KDNY | Chinook Therapeutics Inc |
| 07/28/2023 | 8:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:KDNY | Chinook Therapeutics Inc |